| | |

Standard Mesothelioma Chemotherapy with Avastin: More Good News

ByAlex Strauss
Standard Mesothelioma Chemotherapy

Another new study suggests that adding a third drug to standard mesothelioma chemotherapy might lead to better treatment outcomes. 

Several recent studies show immunotherapy drugs like Keytruda and IMFINZI may boost the effectiveness of chemotherapy. 

The newest report focuses on the monoclonal antibody, bevacizumab (Avastin). Japanese researchers back up what others have found. They say most patients did well on a combination of Avastin and standard mesothelioma chemotherapy. 

Drug Blocks Blood Vessel Formation

Like all body tissues, mesothelioma tumors need blood vessels to grow and thrive. Angiogenesis is the process by which tumors create their own new blood vessels. 

Avastin works by blocking this process. Without an adequate blood supply, a mesothelioma tumor may be more susceptible to standard mesothelioma chemotherapy. 

Doctors already use Avastin to treat lung cancer, colon cancer, glioblastoma, and renal-cell cancer. The new study is the first one to evaluate it for Japanese pleural mesothelioma patients.

Making Standard Mesothelioma Chemotherapy Better

Chemotherapy is only moderately effective against malignant mesothelioma. But it is the best hope for patients who are not candidates for mesothelioma surgery.  

Standard mesothelioma chemotherapy combines Alimta (pemetrexed) and a platinum drug. The platinum drug is usually cisplatin or carboplatin. The combination gives patients an average of four extra months of life. 

The goal of the Japanese trial was to see if Avastin could safely extend that. Seven pleural mesothelioma patients enrolled. They received six rounds of Avastin plus standard mesothelioma chemotherapy. Patients could stay on Avastin for up to a year. 

The Avastin regimen was not without drawbacks. Every patient had some sort of gastrointestinal problem. Two patients dropped out because of these issues. 

On the up side, the combination did seem to help. Mesothelioma tumors stopped growing in four patients and shrunk in two patients. The researchers conclude that adding Avastin to standard mesothelioma chemotherapy has merit. 

“Bevacizumab plus cisplatin/pemetrexed, then bevacizumab, was well tolerated in Japanese patients with malignant pleural mesothelioma,” they write. 

Other Benefits of Chemotherapy with Avastin

Avastin may have other benefits for mesothelioma patients. In France, chemotherapy with Avastin is already standard-of-care for mesothelioma. A 2019 French study showed the combination reduced pain and cut the risk for peripheral neuropathy. (Some chemotherapy drugs can damage nerves that control the arms and legs.)

Three years earlier, the French MAPS study showed that adding Avastin to standard mesothelioma chemotherapy improved survival by 23 percent. The US National Comprehensive Cancer Network guidelines list it as an option for first-line mesothelioma treatment. 

Sources:

Nakano, T, et al, “Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study, September 7, 2020, Asia Pacific Journal of Clinical Oncology, Epub ahead of print, https://pubmed.ncbi.nlm.nih.gov/32893992/

Eberst, G, et al, “Health-related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial”, June 7, 2019, Clinical Cancer Research, Epub ahead of print, http://clincancerres.aacrjournals.org/content/early/2019/06/07/1078-0432.CCR-18-2860

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    ByAlex Strauss

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    ByAlex Strauss

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    ByAlex Strauss

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    ByAlex Strauss

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    ByAlex Strauss

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    ByAlex Strauss

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…